Verrica Pharmaceuticals (VRCA)

• Market cap: $98.3M
• 1 day: -1.76%
• 5 days: 20.59%
• 1 month: 10.61%
• 3 months: -22.35%
• 6 months: 29.47%
• Year to date: -25.9%
• 1 year: 2.67%
• 5 years: -96.37%
• 10 years: -96.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Employees: 71